DOCSLIB.ORG

Isct2021 Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Isct2021 Program MAY 26–28 ISCT2021 VIRTUAL Orchestrating Global CGT Translation Building Consensus for the Path Forward PROGRAM MAY 26–28 ISCT2021 VIRTUAL WELCOME FROM THE ISCT PRESIDENT Dear Friends and Colleagues, a day, 3 concurrent tracks), and all of which will be available for viewing on demand for the remainder of 2021. Extra effort We ARE friends AND colleagues! Just as ISCT is a Society has been invested for enhanced virtual Networking, with a full like no other, ISCT 2021 Virtual New Orleans will continue ISCT 2021 Networking Day on May 25. During the Networking our breakthrough last year in providing a virtual platform Day, you can attend the inaugural Investigators to Investors with industry leading presentation technology that is im- (I to I) Workshop, organized by the ISCT Business Models & mersive and informative, enlightening and engaging in a Investment Commercialization Sub-Committee, which will multi-dimensional platform that reflects our Society values. bring together cell and gene therapy investors for a half-day We promote innovation in translational research. We strive educational event providing unparalleled access to cell and for excellence in everything we do. We respect and support gene therapy key opinion leaders. diversity and inclusivity. We uphold the highest ethical stan- dards. We serve our members and advocate for our Society. The anchor for your ISCT program is the six plenary ses- sions. Leading off, our President Elect Jacques Galipeau Over the past year, the world has seen great tragedy and will chair the plenary “COVID-19: Understanding the Path scientific advances to meet pandemic challenges. The field Forward for Mesenchymal Stromal Cell Therapies.” For the of cell and gene therapy continues to break new ground, Presidential Plenary, representing the Commercialization advancing medical care for patients worldwide. Recognizing Theme, “Integrating Science, Regulatory Oversight, and that our field is at a crossroads, we’ve built the program Commercialization for the New Wave of Cell and Gene around a theme: “Orchestrating Global CGT Translation: Therapies” will feature a scientific leader (Matthew Porteus Building Consensus for the Path Forward”. That is why of Stanford), a regulatory leader (Peter Marks of FDA-CBER), I am so grateful and proud of our Organizing Committee and an industry leader (Arie Belldegrun of Allogene, formerly led by co-chairs Jaap Boelens, MD, PhD, (Chair, Stem Cell CEO of Kite). Each will take you through their personal career Engineering Committee), Karen Nichols, Esq. (ISCT Chief journey, the state of the field, and discuss paths forward. I Regulatory Officer), and George Muschler, MD (Co-Chair, am very excited that for the first time, the Presidential Plenary Orthopedic and Musculoskeletal Therapies Committee). will have a co-chair, Early Stage Professional Shabnum Patel, Why is the ISCT 2021 New Orleans Virtual different from all PhD, as part of a new ISCT leadership mentoring program. other meetings? On a mission, and with incredible passion, One of the more rapidly developing areas of our field will the Organizing Committee has crafted an absolutely stellar be featured in Plenary III, “First in Man Exosome Trials”. program reflecting the translational pathway, integrating our Plenary IV will feature a moderated (largely peaceful?) de- Scientific Committees, our Commercialization Committee, bate with leading experts on “BMT vs Gene Therapy vs No our Global Regulatory Task Force, our Lab Practices Cell Therapy: Accessibility, Cost, and Outcomes”, Plenary Committee, and our Presidential Task Force on the Use of V will chart the future for “Safe and Effective Translation Unproven and/or Unethical Cell and Gene Therapies. This in Tissue Engineering and Regenerative Medicine” and the integration reflects the orchestration of teams needed to finale, Plenary VI from the ISCT Immuno & Gene Therapies develop cell and gene therapies, technologists, academics, Committee will debate the applications of CAT-T/NK Cells: manufacturing experts, clinicians, quality assurance teams, “Perspectives on Autologous versus Allogeneic Therapies.” regulators, industry members, laboratory specialists, ad- Supplementing these Plenaries will be Program Track ses- vanced practice practitioners, pharmacists, clinical research sions in six key topic areas in translational science, as well as nurses and coordinators. key issues in regulation and industry: Mesenchymal Stromal At ISCT 2021 New Orleans Virtual, from your home or office, Cells, Commercialization, Exosomes, Stem Cell Engineering, or local park if you wish, you will explore a virtual environ- Tissue Engineering & Regenerative Medicine, and Immuno & ment made just for you and your interests. You will be able Gene Therapies. Corporate Symposia, Tutorials, and Global to network with peers, see leading exhibits, posters, and Showcase sessions will feature the latest technology devel- presentations and discussions with a constellation of global opments. But wait, there’s more! Four Regulatory sessions, experts- the majority of which will be LIVE May 26-28 (9 hours three Lab & Cell Processing sessions, a Veterinary Medicines 2 session, and two Advanced Practice Professionals sessions round out the programming May 26-28, remembering that all LIVE and pre-recorded sessions will be available through December 31, 2021. Also be sure not to miss the presenta- tions of three ISCT awards for Career Achievement to Donald Kohn, MD., PhD, the inaugural Darwin J. Prockop Mentoring Award to ISCT Past President Cath Bollard, MBChB, MD, and the inaugural Le Prix Luc Sensebé Innovation Award, to Keith Thompson CBE, and much more. Make sure you tune in for the launch of ‘ISCT TV’! Join ISCT leaders as they live stream on YouTube before and after the Plenary Sessions for a community based approach to recre- ating the hallway conversations and coffee chats we miss in a virtual setting. Plus, see exclusive behind the scenes footage of our virtual meeting – there will be bloopers! It’s engaging, it’s fun, it’s ISCT. I would like to thank Jaap, Karen, George and the entire Organizing Committee and our extraordinary Head Office staff for exceptional effort in bringing this meeting to you. Enjoy, learn, connect, and let us all work towards a recovery where we can laissez les bons temps rouler! Bruce Levine, PhD ISCT President June 2020 – June 2022 3 MAY 26–28 ISCT2021 VIRTUAL WELCOME FROM THE ISCT 2021 CO-CHAIRS A warm welcome to ISCT 2021 New Orleans VIRTUAL! an in-person meeting. Prepare yourselves for the hustle and This year’s Annual Meeting is a testament to the unprecedent- bustle that are the trademark of any meeting worth attending! ed resilience shown by the cell and gene therapy community Tune into live discussions of ongoing events in the commu- of ISCT. We welcome you to re-connect, communicate, and nity-driven programing unveiled in ISCT TV! ISCT TV will translate at ISCT 2021 New Orleans VIRTUAL, a LIVE and provide insider perspectives on past and upcoming sessions, engaging meeting. and how key session insights connect across the meeting on Our theme this year is, Orchestrating Global CGT Translation: the theme of building consensus. Led by our virtual hosting Building Consensus for the Path Forward, and the key questions teams and ESP ambassadors, ISCT TV is above all, a perfect we and our field must undertake to solve as we approach a opportunity to see the ISCT community in action as you new wave of cell and gene therapies. enjoy a cup of coffee, or even a glass of wine, before your next session begins! We have organized an Annual Meeting that includes the di- verse perspectives of our membership in science, regulation, It was important for us to incorporate the feedback you pro- and commercialization, so that we can drive concerted and vided after ISCT 2020 – so, this year’s meeting will provide impactful advancement across the field and around the globe. improved networking and partnering opportunities. The ISCT 2021 Networking Day provides delegates with a full day Our meeting spans six key themes, as well as sessions on of activities before LIVE sessions begin. Keep an eye out for regulatory perspectives and leading industry innovations: sessions tailored to your interests: • Mesenchymal Stromal Cells • Regional Town Halls • Exosomes • ESP Networking Sessions • Stem Cell Engineering • Investigators to Investors (I to I) Workshop • Tissue Engineering & Regenerative Medicine • Poster Hall • Immuno & Gene Therapies • Commercialization Chat or video call one-to-one with your colleagues around the globe as you participate in all the activities of the ISCT Each theme is spearheaded by a plenary session covering 2021 Networking Day. major challenges and opportunities in the field. Each theme is then further developed in four related sessions utilizing Visit the exhibit hall to see exciting and state of the art inno- key opinion leaders to shine a light on in-depth approaches vations from industry partners and members. Keep an eye and crucial developments from their fields of expertise. Each out for a great suite of Corporate Symposia, Tutorials, Global year, ISCT meetings bring together the very best in the cell Showcase Presentations, and Hot Topic Roundtables. and gene therapy field to debate hot topics and present state Deepest thanks to all the members who have contributed of the art research. This year, we are proud to bring you over to making this program a reality. Members from around 200 preeminent speakers and chairs, whose raison d’être will the globe on the organizing committee, speaker roster, the be to share with you the information and the insights that ISCT committees, and many others have come together to will shape the future of the field as we begin the new wave of create a community spirit and a virtual event like no other. cell and gene therapies. Please enjoy four days of engaging presentations, focused In a year where we long to regain personal interactions be- networking, and excitement with our colleagues from around yond video calls and recordings, we have worked to create the globe.
Load more

Recommended publications
  • Attenuation of Pathogenic Immune Responses During Infection with Human and Simian Immunodeficiency Virus (HIV/SIV) by the Tetracycline Derivative Minocycline
    Attenuation of Pathogenic Immune Responses during Infection with Human and Simian Immunodeficiency Virus (HIV/SIV) by the Tetracycline Derivative Minocycline Julia L. Drewes1, Gregory L. Szeto1¤, Elizabeth L. Engle1, Zhaohao Liao1, Gene M. Shearer2,M. Christine Zink1*, David R. Graham1,3* 1 Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, 2 Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, 3 Johns Hopkins Bayview Proteomics Center, Department of Medicine, Division of Cardiology, Johns Hopkins School of Medicine Bayview Campus, Baltimore, Maryland, United States of America Abstract HIV immune pathogenesis is postulated to involve two major mechanisms: 1) chronic innate immune responses that drive T cell activation and apoptosis and 2) induction of immune regulators that suppress T cell function and proliferation. Both arms are elevated chronically in lymphoid tissues of non-natural hosts, which ultimately develop AIDS. However, these mechanisms are not elevated chronically in natural hosts of SIV infection that avert immune pathogenesis despite similarly high viral loads. In this study we investigated whether minocycline could modulate these pathogenic antiviral responses in non-natural hosts of HIV and SIV. We found that minocycline attenuated in vitro induction of type I interferon (IFN) and the IFN-stimulated genes indoleamine 2,3-dioxygenase (IDO1) and TNF-related apoptosis inducing ligand (TRAIL) in human plasmacytoid dendritic cells and PBMCs exposed to aldrithiol-2 inactivated HIV or infectious influenza virus. Activation- induced TRAIL and expression of cytotoxic T-lymphocyte antigen 4 (CTLA-4) in isolated CD4+ T cells were also reduced by minocycline.
    [Show full text]
  • University of Groningen Mechanics of Extracellular Vesicles
    University of Groningen Mechanics of extracellular vesicles derived from malaria parasiteinfected Red Blood Cells Sorkin, Raya; Vorselen, Daan; Ofir-Birin, Yifat; Roos, Wouter H.; MacKintosh, Fred C.; Regev-Rudzki, Neta; Wuite, Gijs J. L. Published in: Journal of Extracellular Vesicles DOI: 10.3402/jev.v5.31552 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Publication date: 2016 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Sorkin, R., Vorselen, D., Ofir-Birin, Y., Roos, W. H., MacKintosh, F. C., Regev-Rudzki, N., & Wuite, G. J. L. (2016). Mechanics of extracellular vesicles derived from malaria parasiteinfected Red Blood Cells. Journal of Extracellular Vesicles, 5, 86. https://doi.org/10.3402/jev.v5.31552 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 12-11-2019
    [Show full text]
  • Human Perivascular Stem Cell-Derived Extracellular Vesicles Mediate Bone
    RESEARCH ARTICLE Human perivascular stem cell-derived extracellular vesicles mediate bone repair Jiajia Xu1, Yiyun Wang1, Ching-Yun Hsu1, Yongxing Gao1, Carolyn Ann Meyers1, Leslie Chang1, Leititia Zhang1,2, Kristen Broderick3, Catherine Ding4, Bruno Peault4,5,6, Kenneth Witwer7,8, Aaron Watkins James1* 1Department of Pathology, Johns Hopkins University, Baltimore, United States; 2Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, Shenyang, China; 3Department of Surgery, Johns Hopkins University, Baltimore, United States; 4Department of Orthopaedic Surgery, Orthopaedic Hospital Research Center, UCLA, Orthopaedic Hospital, Los Angeles, United States; 5Centre For Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; 6MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom; 7Department of Molecular and Comparative Pathobiology, Johns Hopkins University, Baltimore, United States; 8Department of Neurology, Johns Hopkins University, Baltimore, United States Abstract The vascular wall is a source of progenitor cells that are able to induce skeletal repair, primarily by paracrine mechanisms. Here, the paracrine role of extracellular vesicles (EVs) in bone healing was investigated. First, purified human perivascular stem cells (PSCs) were observed to induce mitogenic, pro-migratory, and pro-osteogenic effects on osteoprogenitor cells while in non- contact co-culture via elaboration of EVs. PSC-derived EVs shared mitogenic, pro-migratory, and pro-osteogenic properties of their parent cell. PSC-EV effects were dependent on surface- associated tetraspanins, as demonstrated by EV trypsinization, or neutralizing antibodies for CD9 or CD81. Moreover, shRNA knockdown in recipient cells demonstrated requirement for the CD9/ CD81 binding partners IGSF8 and PTGFRN for EV bioactivity. Finally, PSC-EVs stimulated bone repair, and did so via stimulation of skeletal cell proliferation, migration, and osteodifferentiation.
    [Show full text]
  • Announcing the ISEV2020 Special Achievement Award Recipients
    Thomas Jefferson University Jefferson Digital Commons Kimmel Cancer Center Faculty Papers Kimmel Cancer Center 10-1-2020 Announcing the ISEV2020 special achievement award recipients: Andrew Hill and Edit Buzás; and the recipient of the ISEV2020 special education award: Carolina Soekmadji. Kenneth W Witwer Lucia R Languino Alissa M Weaver Marca H Wauben Follow this and additional works at: https://jdc.jefferson.edu/kimmelccfp Part of the Oncology Commons Let us know how access to this document benefits ouy This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Kimmel Cancer Center Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: [email protected]. Received: 30 July 2020 Accepted: 8 September 2020 DOI: 10.1002/jev2.12021 EDITORIAL Announcing the ISEV special achievement award recipients: AndrewHillandEditBuzás;andtherecipientoftheISEV special education award: Carolina Soekmadji The International Society for Extracellular Vesicles (ISEV) is pleased to announce two Special Achievement Awards that were presented at the virtual ISEV2020 annual meeting, 20–22 July 2020. ISEV Special Achievement Awards are given each year to one or more individuals who have made outstanding contributions to the field of extracellular vesicle (EV) research or have per- formed extraordinary service to ISEV (Witwer, Hill, & Tahara, 2019).
    [Show full text]
  • Extracellular Vesicles and Nanoerythrosomes: the Hidden Pearls of Blood Products
    Academic Dissertations from The Finnish Red Cross Blood Service number 64 SAMI VALKONEN | Extracellular Vesicles and Nanoerythrosomes: The Hidden Pearls of Blood Products Blood Nanoerythrosomes: Pearls of Extracellular and Hidden The | Vesicles SAMI VALKONEN SAMI VALKONEN Extracellular Vesicles and Nanoerythrosomes: The Hidden Pearls of Blood Products ISBN 978-952-5457-48-3 (print) ISBN 978-952-5457-49-0 (pdf) ISSN 1236-0341 FRC BS: 64 http://ethesis.helsinki.fi Turku 2019 Painosalama Oy ACADEMIC DISSERTATION, NUMBER 64 Doctoral School of Health Sciences Doctoral Programme in Biomedicine Molecular and Integrative Biosciences Research Programme Faculty of Biological and Environmental Sciences University of Helsinki and Finnish Red Cross Blood Service EXTRACELLULAR VESICLES AND NANOERYTHROSOMES: THE HIDDEN PEARLS OF BLOOD PRODUCTS Sami Valkonen ACADEMIC DISSERTATION To be presented for public examination, with the permission of the Faculty of Biological and Environmental Sciences of the University of Helsinki, in Nevanlinna Auditorium of the Finnish Red Cross Blood Service, Kivihaantie 7, Helsinki, on 19th December 2019, at 12 noon. Helsinki 2019 ACADEMIC DISSERTATIONS FROM THE FINNISH RED CROSS BLOOD SERVICE, NUMBER 64 Supervisors Adjunct Professor Pia Siljander Faculty of Biological and Environmental Sciences University of Helsinki Doctor Saara Laitinen Department of Research & Development Finnish Red Cross Blood Service Thesis Committee Associate Professor Susanna Fagerholm Faculty of Biological and Environmental Sciences University of
    [Show full text]
  • Downloaded From
    Canonical Type I IFN Signaling in Simian Immunodeficiency Virus-Infected Macrophages Is Disrupted by Astrocyte-Secreted CCL2 This information is current as of September 27, 2021. Luna Alammar Zaritsky, Lucio Gama and Janice E. Clements J Immunol published online 9 March 2012 http://www.jimmunol.org/content/early/2012/03/09/jimmun ol.1103024 Downloaded from Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published March 9, 2012, doi:10.4049/jimmunol.1103024 The Journal of Immunology Canonical Type I IFN Signaling in Simian Immunodeficiency Virus-Infected Macrophages Is Disrupted by Astrocyte-Secreted CCL2 Luna Alammar Zaritsky,* Lucio Gama,* and Janice E. Clements*,† HIV-associated neurologic disorders are a mounting problem despite the advent of highly active antiretroviral therapy. To address mechanisms of HIV-associated neurologic disorders, we used an SIV pigtailed macaque model to study innate immune responses in brain that suppress viral replication during acute infection.
    [Show full text]
  • NCUR Proceedings
    NCUR 2021 Proceedings A Diffusion Approach for Plasma Synthesis of Superhard Tantalum Borides Physics/Astronomy - Time: Tue 3:30pm-4:30pm - Session Number: 745 Aaditya Rau, Dr. Aaron Catledge, Department of Physics, The University of Alabama at Birmingham, 1720 2nd Ave S, Birmingham, Alabama 35294 Aaditya Rau Tantalum borides are a set of refractory metal compounds that have become of interest due to their desirable mechanical, thermal, and electrical properties. While these compounds have been previously synthesized in a variety of methods, key issues related to sample size, sample integrity, and implementation feasibility limit their use. In this study, a microwave plasma chemical vapor deposition (MPCVD) reactor was used to diffuse boron into tantalum substrates using a feedgas mixture of hydrogen and diborane. Specifically, the role of substrate temperature and substrate bias in influencing the chemical composition and mechanical properties of the borided tantalum was investigated. X-ray diffraction shows that high substrate temperature is favorable for TaB2 formation, with samples made at great than 775°C having a mean surface hardness of 40 GPa along with increased strain in the tantalum body-centered cubic lattice. Once the strained tantalum becomes locally supersaturated with boron, TaB and TaB2 precipitate. The combination of precipitation hardening as well as solid solution hardening may help explain the measured superhardness, as measured by nanoindentation. Application of a negative bias voltage to the substrate during the CVD process was not found to further increase the hardness, and in some cases decreased the measured hardness significantly, possibly due to etching effects from increased ion bombardment. These results show that MPCVD is a viable method for synthesis of superhard borides based on plasma-assisted diffusion.
    [Show full text]
  • Pharmacokinetics and Biodistribution of Extracellular Vesicles Administered Intravenously and Intranasally to Macaca Nemestrina
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.28.454192; this version posted July 29, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina Authors Tom Driedonks1, Linglei Jiang1, Bess Carlson 1, Zheng Han2,3, Guanshu Liu2,3, Suzanne E. Queen1, Erin N. Shirk1, Olesia Gololobova1, Lyle Nyberg1, Gabriela Lima1, Kayla Schonvisky1, Natalie Castell1, Mitchel Stover, Selena Guerrero-Martin1,4, Riley Richardson1, Barbara Smith5, Charles P. Lai6, Jessica M. Izzi1, Eric K. Hutchinson1, Kelly A.M. Pate1,4, Kenneth W. Witwer1,7,8,* 1. Dept. Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, US 2. Russell H. Morgan Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, US 3. F.M. Kirby Research Center, Kennedy Krieger Institute, Baltimore, MD, US 4. Division of ComParative Medicine and DePartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, US 5. DePt. Cell Biology, Johns HoPkins University School of Medicine, Baltimore, MD, US 6. Institute of Atomic and Molecular Sciences, Academia Sinica, TaiPei, Taiwan 7. DePt. of Neurology, Johns HoPkins University School of Medicine, Baltimore, MD, US 8. The Richman Family Precision Medicine Center of Excellence in Alzheimer’s Disease, Johns Hopkins University School of Medicine, Baltimore, MD, US *CorresPondence: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.28.454192; this version posted July 29, 2021.
    [Show full text]
  • Highlights of the São Paulo ISEV Workshop on Extracellular Vesicles in Cross-Kingdom Communication
    Journal of Extracellular Vesicles ISSN: (Print) 2001-3078 (Online) Journal homepage: http://www.tandfonline.com/loi/zjev20 Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication Rodrigo P. Soares, Patrícia Xander, Adriana Oliveira Costa, Antonio Marcilla, Armando Menezes-Neto, Hernando Del Portillo, Kenneth Witwer, Marca Wauben, Esther Nolte-`T Hoen, Martin Olivier, Miriã Ferreira Criado, Luis Lamberti P. da Silva, Munira Muhammad Abdel Baqui, Sergio Schenkman, Walter Colli, Maria Julia Manso Alves, Karen Spadari Ferreira, Rosana Puccia, Peter Nejsum, Kristian Riesbeck, Allan Stensballe, Eline Palm Hansen, Lorena Martin Jaular, Reidun Øvstebø, Laura de la Canal, Paolo Bergese, Vera Pereira-Chioccola, Michael W. Pfaffl, Joëlle Fritz, Yong Song Gho & Ana Claudia Torrecilhas To cite this article: Rodrigo P. Soares, Patrícia Xander, Adriana Oliveira Costa, Antonio Marcilla, Armando Menezes-Neto, Hernando Del Portillo, Kenneth Witwer, Marca Wauben, Esther Nolte- `T Hoen, Martin Olivier, Miriã Ferreira Criado, Luis Lamberti P. da Silva, Munira Muhammad Abdel Baqui, Sergio Schenkman, Walter Colli, Maria Julia Manso Alves, Karen Spadari Ferreira, Rosana Puccia, Peter Nejsum, Kristian Riesbeck, Allan Stensballe, Eline Palm Hansen, Lorena Martin Jaular, Reidun Øvstebø, Laura de la Canal, Paolo Bergese, Vera Pereira-Chioccola, Michael W. Pfaffl, Joëlle Fritz, Yong Song Gho & Ana Claudia Torrecilhas (2017) Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication, Journal of Extracellular Vesicles, 6:1, 1407213, DOI: 10.1080/20013078.2017.1407213 To link to this article: https://doi.org/10.1080/20013078.2017.1407213 © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
    [Show full text]
  • Summary of the ISEV Workshop on Extracellular Vesicles As Disease Biomarkers, Held in Birmingham, UK, During December 2017
    Journal of Extracellular Vesicles ISSN: (Print) 2001-3078 (Online) Journal homepage: https://www.tandfonline.com/loi/zjev20 Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017 Aled Clayton, Dominik Buschmann, J. Brian Byrd, David R. F. Carter, Lesley Cheng, Carolyn Compton, George Daaboul, Andrew Devitt, Juan Manuel Falcon-Perez, Chris Gardiner, Dakota Gustafson, Paul Harrison, Clemens Helmbrecht, An Hendrix, Andrew Hill, Andrew Hoffman, Jennifer C. Jones, Raghu Kalluri, Ji Yoon Kang, Benedikt Kirchner, Cecilia Lässer, Charlotte Lawson, Metka Lenassi, Carina Levin, Alicia Llorente, Elena S. Martens- Uzunova, Andreas Möller, Luca Musante, Takahiro Ochiya, Ryan C Pink, Hidetoshi Tahara, Marca H. M. Wauben, Jason P. Webber, Joshua A. Welsh, Kenneth W. Witwer, Hang Yin & Rienk Nieuwland To cite this article: Aled Clayton, Dominik Buschmann, J. Brian Byrd, David R. F. Carter, Lesley Cheng, Carolyn Compton, George Daaboul, Andrew Devitt, Juan Manuel Falcon-Perez, Chris Gardiner, Dakota Gustafson, Paul Harrison, Clemens Helmbrecht, An Hendrix, Andrew Hill, Andrew Hoffman, Jennifer C. Jones, Raghu Kalluri, Ji Yoon Kang, Benedikt Kirchner, Cecilia Lässer, Charlotte Lawson, Metka Lenassi, Carina Levin, Alicia Llorente, Elena S. Martens-Uzunova, Andreas Möller, Luca Musante, Takahiro Ochiya, Ryan C Pink, Hidetoshi Tahara, Marca H. M. Wauben, Jason P. Webber, Joshua A. Welsh, Kenneth W. Witwer, Hang Yin & Rienk Nieuwland (2018) Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017, Journal of Extracellular Vesicles, 7:1, 1473707, DOI: 10.1080/20013078.2018.1473707 To link to this article: https://doi.org/10.1080/20013078.2018.1473707 © 2018 The Author(s).
    [Show full text]
  • Summary of the ISEV Workshop on Extracellular Vesicles As Disease Biomarkers, Held in Birmingham, UK, During December 2017
    Journal of Extracellular Vesicles ISSN: (Print) 2001-3078 (Online) Journal homepage: http://www.tandfonline.com/loi/zjev20 Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017 Aled Clayton, Dominik Buschmann, J. Brian Byrd, David R. F. Carter, Lesley Cheng, Carolyn Compton, George Daaboul, Andrew Devitt, Juan Manuel Falcon-Perez, Chris Gardiner, Dakota Gustafson, Paul Harrison, Clemens Helmbrecht, An Hendrix, Andrew Hill, Andrew Hoffman, Jennifer C. Jones, Raghu Kalluri, Ji Yoon Kang, Benedikt Kirchner, Cecilia Lässer, Charlotte Lawson, Metka Lenassi, Carina Levin, Alicia Llorente, Elena S. Martens- Uzunova, Andreas Möller, Luca Musante, Takahiro Ochiya, Ryan C Pink, Hidetoshi Tahara, Marca H. M. Wauben, Jason P. Webber, Joshua A. Welsh, Kenneth W. Witwer, Hang Yin & Rienk Nieuwland To cite this article: Aled Clayton, Dominik Buschmann, J. Brian Byrd, David R. F. Carter, Lesley Cheng, Carolyn Compton, George Daaboul, Andrew Devitt, Juan Manuel Falcon-Perez, Chris Gardiner, Dakota Gustafson, Paul Harrison, Clemens Helmbrecht, An Hendrix, Andrew Hill, Andrew Hoffman, Jennifer C. Jones, Raghu Kalluri, Ji Yoon Kang, Benedikt Kirchner, Cecilia Lässer, Charlotte Lawson, Metka Lenassi, Carina Levin, Alicia Llorente, Elena S. Martens-Uzunova, Andreas Möller, Luca Musante, Takahiro Ochiya, Ryan C Pink, Hidetoshi Tahara, Marca H. M. Wauben, Jason P. Webber, Joshua A. Welsh, Kenneth W. Witwer, Hang Yin & Rienk Nieuwland (2018) Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017, Journal of Extracellular Vesicles, 7:1, 1473707, DOI: 10.1080/20013078.2018.1473707 To link to this article: https://doi.org/10.1080/20013078.2018.1473707 © 2018 The Author(s).
    [Show full text]
  • Journal of Extracellular Vesicles, Taylor & Francis, 2018, 7 (1), Pp.1535750
    Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Thery, Kenneth Witwer, Elena Aikawa, Maria Jose Alcaraz, Johnathon Anderson, Ramaroson Andriantsitohaina, Anna Antoniou, Tanina Arab, Fabienne Archer, Georgia Atkin-Smith, et al. To cite this version: Clotilde Thery, Kenneth Witwer, Elena Aikawa, Maria Jose Alcaraz, Johnathon Anderson, et al.. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, Taylor & Francis, 2018, 7 (1), pp.1535750. 10.1080/20013078.2018.1535750. hal-02323217 HAL Id: hal-02323217 https://hal.archives-ouvertes.fr/hal-02323217 Submitted on 10 Mar 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial| 4.0 International License JOURNAL OF EXTRACELLULAR
    [Show full text]